MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-22-0005543
Vipragen Biosciences Private Limited - pharma in Mysore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹18.35 Cr
▲ 46% YoY
Net profit · FY 2025
₹4.28 Cr
Net margin 23.3%
EBITDA · FY 2025
₹3.59 Cr
EBITDA margin 19.6%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.09 Cr
Issued & subscribed
Open charges
₹5.52 Cr
Satisfied ₹6.35 Cr
Company age
14 yrs
Est. 2012
Employees · EPFO
75
Provident fund records
About Vipragen Biosciences Private Limited
Data last updated:
Vipragen Biosciences Private Limited is a private limited company based in Mysore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 11 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2012PTC063955. Its GSTIN is 29AAECV0673P1ZN (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.09 Cr. It is led by directors including Siddamadappa Chandrashekaran (Managing Director) and Umesh Devurkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 67B Hootagalli Industrial Area, Mysore, Karnataka, India – 570018.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.35 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹4.28 Cr (net margin 23.3%) and EBITDA of ₹3.59 Cr (EBITDA margin 19.6%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 56% over five years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vipragen. As per MCA filings, the company has open charges of ₹5.52 Cr and satisfied charges of ₹6.35 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 16 deals on record (7 secondary share transfers, 6 rights issues, 2 funding rounds), with disclosed funding of ₹6.92 Cr; the latest was in August 2023. Its 6 peer companies in the Pharma industry (Biosciences, Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 3 larger and 3 smaller; the largest is G7 Synergon Private Limited with revenue of ₹18.97 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 5 overdue payments to 4 micro and small suppliers.
Vipragen Biosciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0005543). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vipragen.com.
Company details
CIN U73100KA2012PTC063955
Registration Number 063955
Incorporation Date 11 May 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-22-0005543
Key People
Siddamadappa Chandrashekaran Managing Director Umesh Devurkar Director Pallavur Viswanathan Harikrishnan Nominee Director Recognitions & Rankings of Vipragen Biosciences
Contact details
Vipragen Biosciences Private Limited's registered office is in Mysore, Karnataka. Its website is vipragen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address67B Hootagalli Industrial Area, Mysore, Karnataka, India – 570018
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Vipragen Biosciences Private Limited, buy the company report.
Comprehensive company report
Vipragen Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vipragen Biosciences operates one associated brand: Vipragen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drug discovery and development services are provided for pharmaceuticals. | vipragen.com |
Business activity
The main business activity of Vipragen Biosciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Vipragen Biosciences Private Limited, buy the company report.
Financials of Vipragen Biosciences Private Limited
FY 2025 filings availableVipragen Biosciences Private Limited reported revenue of ₹18.35 Cr (up 46% YoY) for FY 2025.
Revenue · FY 2025
₹18.35 Cr ▲ 46%
Net profit · FY 2025
₹4.28 Cr margin 23.3%
EBITDA · FY 2025
₹3.59 Cr margin 19.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 39%
5 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 68%
3 years · compounded
▲ 60%
5 years · compounded
▲ 60%
Revenue has grown at a compounded annual rate (CAGR) of 56% over five years, including 46% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.6% | ||||
| Net Profit Margin | 23.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vipragen Biosciences Private Limited, buy the company report.
Board of directors of Vipragen Biosciences Private Limited
Vipragen Biosciences has 6 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Devurkar Also directs: Rowan Agro Nature Private Limited | Director | 17 Sep 2012 | 14 Years 1 Months | Current |
| Pallavur Viswanathan Harikrishnan | Nominee Director | 03 Oct 2023 | 3 Years 1 Months | Current |
| Siddamadappa Chandrashekaran | Managing Director | 05 Oct 2015 | 11 Years 1 Months | Current |
| Yashas | Director | 10 Feb 2021 | 5 Years 8 Months | Current |
| Kannasandra Pushpalatha Also directs: Glogene Bio Private Limited, Cypa Therapeutics Private Limited | Director | 01 Jul 2014 | 12 Years 4 Months | Current |
| Patlapati Harsha Samaraditya Also directs: Anjaniputraa Dwelling LLP, Nuxi Cosmeceutics LLP | Additional Director | 03 Nov 2025 | 1 Years 0 Months | Current |
Peer comparison
Vipragen Biosciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Biosciences, Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G7 Synergon Private Limited | ₹18.97 Cr (FY 2025) | 73.0% | Bangalore, Karnataka, India | |||
| Cod Research Private Limited | ₹18.93 Cr (FY 2024) | 244.0% | Ahmedabad, Gujarat, India | |||
| Sci-Tech Centre | ₹18.62 Cr (FY 2025) | -38.0% | Mumbai, Maharashtra, India | |||
| Vipragen Biosciences Private Limitedthis company | ₹18.35 Cr (FY 2025) | ₹4.28 Cr | 23.3% | 46.0% | 75 | Mysore, Karnataka, India |
| Vivancemed India Private Limited | ₹18.19 Cr (FY 2024) | 20.0% | Bangalore, Karnataka, India | |||
| Monolom India Pharma Private Limited | ₹18.17 Cr (FY 2025) | -1.0% | Pune, Maharashtra, India | |||
| Finoso Pharma Private Limited | ₹17.69 Cr (FY 2025) | -7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vipragen Biosciences Private Limited, buy the company report.
Auditor
Vipragen Biosciences Private Limited is audited by KIRTANE & PANDIT LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KIRTANE & PANDIT LLP | FY 2023 | 105215 W/W 100057 |
Shareholding
The shareholding of Vipragen Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vipragen Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.52 Cr
Satisfied charges
₹6.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2025 | 101192726 | Hdfc Bank Limited | ₹12.1 Lakh | Open | |
| 28 Dec 2023 | 100914735 | Hdfc Bank Limited | ₹4.49 Cr | Open | |
| 31 May 2022 | 100606499 | Others | ₹91 Lakh | Open | |
| 19 Jan 2016 | 10627000 | State Bank of Mysore | ₹2.7 Cr | Satisfied | |
| 27 Sep 2013 | 10455117 | State Bank of India | ₹3.65 Cr | Satisfied |
To see the full charge records of Vipragen Biosciences Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Vipragen Biosciences Private Limited has 16 deals on record (7 secondary share transfers, 6 rights issues, 2 funding rounds), with disclosed funding of ₹6.92 Cr; the latest was in August 2023.
Total deals
16
Secondary share transfers
7
Rights issues
6
Funding rounds
2
Convertible or debt financing
1
Disclosed funding
₹6.92 Cr
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Sanedhapa Solutions Private Limited , 2 individuals |
| Jan 2018 | Rights issue | ₹1.71 Cr | Investors: Advina Global Healthcare LLP , 3 individuals |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Genei Laboratories Private Limited |
| Jul 2017 | Rights issue | ₹1.35 Cr | Investors: Advina Global Healthcare LLP , 2 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Healthx Enterprises Private Limited |
To see the full deal history of Vipragen Biosciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vipragen Biosciences Private Limited has 1 court case on record: 1 filed by Vipragen Biosciences. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against The Assistant Commissioner of Commercial Taxes | Disposed |
To see the full case history of Vipragen Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Vipragen Biosciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 5 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Kirtane & Pandit LLP | |||
| Juniper Life Sciences Private Limited | |||
| Raghu Chemicals |
To see the full MSME payment records of Vipragen Biosciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Vipragen Biosciences Private Limited has a workforce of 75 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
75
Active EPFO establishments
1
Employee growth
20.97%
GST
Vipragen Biosciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECV0673P1ZN | Karnataka | Active | 01 Jul 2017 |
| 37AAECV0673P1ZQ | Andhra Pradesh | Active | 07 Sep 2020 |
To see the full GST registrations and return filing status of Vipragen Biosciences Private Limited, buy the company report.
Recent activity
Vipragen Biosciences Private Limited has 18 board changes on record since 2012: 6 appointments and 12 cessations. The latest: Patlapati Harsha Samaraditya was appointed as Additional Director on 03 Nov 2025.
Appointed
Patlapati Harsha Samaraditya was appointed as Additional Director.
AGM
Vipragen Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.12 Cr with Charge ID 101192726 was registered on 18 Sep 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 4.49 Cr registered on 28 Dec 2023 with Charge ID 100914735 was modified on 30 Jun 2025.
Filing
Vipragen Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge registered on 19 Jan 2016 via Charge ID 10627000 with State Bank Of Mysore was fully satisfied on 15 Mar 2024.
Charges
A charge registered on 27 Sep 2013 via Charge ID 10455117 with State Bank Of India was fully satisfied on 13 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.49 Cr with Charge ID 100914735 was registered on 28 Dec 2023.
Ceased
Jayakumar Arkoni Raghupathy ceased to be Nominee Director.
Appointed
Pallavur Viswanathan Harikrishnan was appointed as Nominee Director.
Charges
A charge with State Bank Of India of Rs. 3.65 Cr registered on 27 Sep 2013 with Charge ID 10455117 was modified on 12 Sep 2022.
Charges
A charge with Others amounted to Rs. 0.91 Cr with Charge ID 100606499 was registered on 31 May 2022.
18 earlier events are in the company report.
News
Frequently asked questions
Vipragen Biosciences is an active private limited company based in Mysore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 11 May 2012 (14+ years old) and is registered under CIN U73100KA2012PTC063955.
Vipragen Biosciences has 6 current directors:
- Siddamadappa Chandrashekaran - Managing Director
- Umesh Devurkar - Director
- Pallavur Viswanathan Harikrishnan - Nominee Director
- Yashas - Director
- Kannasandra Pushpalatha - Director
- Patlapati Harsha Samaraditya - Additional Director
The latest financial statements of Vipragen Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vipragen Biosciences is 29AAECV0673P1ZN, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAECV0673P1ZQ (Andhra Pradesh).
The CIN (Corporate Identification Number) of Vipragen Biosciences is U73100KA2012PTC063955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vipragen Biosciences has 1 court case on record: 1 filed by the company.
Vipragen Biosciences was incorporated on 11 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Vipragen Biosciences has 16 deals on record (7 secondary share transfers, 6 rights issues, 2 funding rounds), with disclosed funding of ₹6.92 Cr; the latest was in August 2023.
The peers of Vipragen Biosciences by revenue are G7 Synergon Private Limited, Cod Research Private Limited, Sci-Tech Centre, Vivancemed India Private Limited, Monolom India Pharma Private Limited and 1 more, all in the Pharma industry (Biosciences, Contract Research), with the same principal business activity (scientific research and development).
Patlapati Harsha Samaraditya was appointed as Additional Director on 03 Nov 2025. Jayakumar Arkoni Raghupathy ceased to be Nominee Director on 03 Oct 2023. Pallavur Viswanathan Harikrishnan was appointed as Nominee Director on 03 Oct 2023. Vipragen Biosciences has 18 board changes on record in total.
Yes, Vipragen Biosciences is registered as a small enterprise under Udyam registration (number: UDYAM-KR-22-0005543).
Vipragen Biosciences has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 5 overdue payments to 4 micro and small suppliers. The latest return was filed on 27 Apr 2022.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages